Rubella Infectious Period
The infectious period for rubella extends from approximately 7 days before rash onset to 7 days after rash onset, with peak contagiousness occurring when the rash first appears. 1
Transmission Timeline
Period of Maximal Communicability:
- The virus is shed in nasopharyngeal secretions for approximately 7 days before and 7 days after the rash becomes visible, making the total infectious window approximately 14 days. 1, 2
- An infected person is most contagious at the time the rash first appears, though transmission can occur throughout the entire period. 1
Transmission Mechanism:
- Rubella is transmitted through direct or droplet contact from nasopharyngeal secretions. 1
- The virus is present in nasopharyngeal secretions, blood, feces, and urine during clinical illness. 2
- Rubella is less contagious than measles, though still readily transmissible. 1
Critical Clinical Considerations
Asymptomatic Transmission:
- Infection is asymptomatic in 25%-50% of cases, yet these individuals remain infectious and can transmit the virus. 1
- Patients with subclinical disease are also infectious during the same timeframe. 2
Incubation Period:
- The incubation period ranges from 12 to 23 days after exposure before symptoms develop. 1
Special Population: Congenital Rubella Syndrome
Prolonged Viral Shedding in Infants:
- Infants with congenital rubella syndrome can shed virus for the first year of life, requiring extended isolation precautions. 3
- Contact isolation precautions should be maintained through the first year of life unless nasopharyngeal and urine cultures are negative for rubella virus. 3
- These infants should be cared for only by personnel known to be immune while diagnostic confirmation is pending. 3
Isolation Recommendations
Standard Isolation Duration:
- Based on the 7-day post-rash infectious period, isolation should continue for at least 7 days after rash onset for postnatal rubella cases. 1
Healthcare Personnel Exposure:
- Identifying persons who lack presumptive evidence of rubella immunity during contact investigations provides an opportunity to offer MMR vaccine, though vaccination after exposure is for future protection rather than post-exposure prophylaxis. 1